Skip to main content
. 2022 Sep 21;9:1010693. doi: 10.3389/fcvm.2022.1010693

Figure 1.

Figure 1

Adverse events with SGLT2 inhibitors and their frequencies. Frequency categories are defined according to the following convention: very common (≥1/10), common (≥1/100 to < 1/10), uncommon (≥1/1,000 to < 1/100), rare (≥1/10,000 to < 1/1,000), very rare (< 1/10,000), unknown (cannot be estimated from the available data). Created in BioRender.com.